- Home
- SCLXW vs HOVNP Comparison
SCLXW vs HOVNP Comparison
Compare SCLXW & HOVNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- HOVNP
- Stock Information
- Founded
- SCLXW N/A
- HOVNP N/A
- Country
- SCLXW United States
- HOVNP United States
- Employees
- SCLXW 111
- HOVNP 1878
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- HOVNP Homebuilding
- Sector
- SCLXW Health Care
- HOVNP Consumer Discretionary
- Exchange
- SCLXW Nasdaq
- HOVNP Nasdaq
- Market Cap
- SCLXW N/A
- HOVNP N/A
- IPO Year
- SCLXW N/A
- HOVNP N/A
- Fundamental
- Price
- SCLXW $0.46
- HOVNP $20.00
- Analyst Decision
- SCLXW
- HOVNP
- Analyst Count
- SCLXW 0
- HOVNP 0
- Target Price
- SCLXW N/A
- HOVNP N/A
- AVG Volume (30 Days)
- SCLXW 4.0K
- HOVNP N/A
- Earning Date
- SCLXW 03-07-2025
- HOVNP N/A
- Dividend Yield
- SCLXW N/A
- HOVNP N/A
- EPS Growth
- SCLXW N/A
- HOVNP N/A
- EPS
- SCLXW N/A
- HOVNP N/A
- Revenue
- SCLXW $55,152,000.00
- HOVNP N/A
- Revenue This Year
- SCLXW N/A
- HOVNP N/A
- Revenue Next Year
- SCLXW N/A
- HOVNP N/A
- P/E Ratio
- SCLXW N/A
- HOVNP N/A
- Revenue Growth
- SCLXW 22.02
- HOVNP N/A
- 52 Week Low
- SCLXW $0.18
- HOVNP N/A
- 52 Week High
- SCLXW $0.18
- HOVNP N/A
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- HOVNP 73.76
- Support Level
- SCLXW N/A
- HOVNP $19.60
- Resistance Level
- SCLXW N/A
- HOVNP $20.25
- Average True Range (ATR)
- SCLXW 0.00
- HOVNP 0.27
- MACD
- SCLXW 0.00
- HOVNP -0.06
- Stochastic Oscillator
- SCLXW 0.00
- HOVNP 78.26
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About HOVNP Hovnanian Enterprises Inc Dep Shr Srs A Pfd
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.